过去一年中添加的文章，按日期排序
Mucosal Immunity in COVID-19: A Comprehensive Review
SA Alqahtani - Frontiers in Immunology - frontiersin.org
4 天前 - … well as circulating IgA antibodies in COVID-19, and that it is important … therapeutic,
or prophylactic purposes. The findings from recent studies on mucosal immunity in COVID-19 …
or prophylactic purposes. The findings from recent studies on mucosal immunity in COVID-19 …
[HTML][HTML] Longitudinal Trends in In-Patient Antibiotic Consumption According to the WHO Access, Watch, Reserve (AWaRe) Antibiotic Groups and Cost: An Analysis of …
N Mittal, A Tayal, S Kumar, R Dhawan, N Goel, R Mittal - Antibiotics, 2024 - mdpi.com
4 天前 - … data to formulate effective therapeutic and prophylactic antibiotic use guidelines; and
… with the COVID-19 pandemic, both of which were repurposed for COVID-19 treatment due …
… with the COVID-19 pandemic, both of which were repurposed for COVID-19 treatment due …
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial
6 天前 - … with COVID-19 than immunocompetent people. Prophylactic monoclonal antibody
therapies … conferred through vaccination remains a central prevention strategy for COVID-19. …
therapies … conferred through vaccination remains a central prevention strategy for COVID-19. …
[HTML][HTML] Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of …
B Costa, MJ Gouveia, N Vale - Vaccines, 2024 - mdpi.com
7 天前 - … regarding prophylactic and therapeutic vaccines for viral … The COVID-19 crisis has
exposed significant gaps in our … both the discovery of new therapies and the optimization and …
exposed significant gaps in our … both the discovery of new therapies and the optimization and …
[PDF][PDF] COVID-19 associated pulmonary aspergillosis in critically-ill patients–authors' reply
P Bay, E Audureau, S Fourati… - Annals of …, 2024 - annalsofintensivecare.springeropen …
8 天前 - … tilated COVID-19 patients [3]. It is also crucial to consider the therapeutic implications
of … , no patient in the study received such prophylaxis to our knowledge, as no prospective …
of … , no patient in the study received such prophylaxis to our knowledge, as no prospective …
[PDF][PDF] Potrošnja vitamina C u 2020. godini
F Posavec - zir.nsk.hr
10 天前 - … its prophylactic or therapeutic use in respiratory infections. Evaluation of the efficacy
of high doses of vitamin C for cold prophylaxis … utjecaj pandemije COVID-19 na potrošnju …
of high doses of vitamin C for cold prophylaxis … utjecaj pandemije COVID-19 na potrošnju …
Prevalence of Anti-Interferon Auto-Antibodies in Patients with Antibody Deficiency
12 天前 - … unknown despite high morbidity and mortality for COVID-19 and other viral infections
[6]… replacement therapy or with an IgG less than 4g/L receiving antibiotic prophylaxis were …
[6]… replacement therapy or with an IgG less than 4g/L receiving antibiotic prophylaxis were …
How international guidelines recommend treating children who have severe COVID‐19 or risk disease progression
J Mańdziuk, E Kuchar, M Okarska‐Napierała - Acta Paediatrica, 2024 - Wiley Online Library
13 天前 - … prophylaxis for severe COVID- 19 … COVID- 19 therapy trial demonstrated that
dexamethasone reduced mortality in patients with COVID- 19 who were receiving oxygen therapy.…
dexamethasone reduced mortality in patients with COVID- 19 who were receiving oxygen therapy.…
Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan
T Taniguchi, T Homma, Y Tamai, Y Arita… - Journal of Infection and …, 2024 - Elsevier
14 天前 - … therapy for hematologic malignancies (88.2%) and treatment with B cell-depleting
therapies (57.4%). Overall, 43.6% of patients had no recorded history of medically attended …
therapies (57.4%). Overall, 43.6% of patients had no recorded history of medically attended …
Antiviral activity of probiotics in the prophylaxis and therapy of respiratory infections linked to Coronavirus (COVID-19): Meta-analysis of randomized controlled trials
SC Mokadem, M Naimi, O Alami - … of Biology and …, 2024 - biology-health-science.wren …
15 天前 - … -2, recent studies suggest potential positive impacts of probiotics on COVID-19
patients. … probiotics had significant positive effects on various measures for treating COVID-19. …
patients. … probiotics had significant positive effects on various measures for treating COVID-19. …